Literature DB >> 12141308

Metastatic melanoma in horses.

Katherine Cole MacGillivray1, Raymond W Sweeney, Fabio Del Piero.   

Abstract

The clinical and pathologic findings are reviewed for 14 horses with metastatic melanoma. All were older gray horses, with an average age of 16 years. The most common sites of primary tumors were the ventral tail, perineum, and parotid salivary gland. Metastases were found in multiple locations and caused a variety of clinical syndromes. The most common sites for metastases were the lymph nodes, liver, spleen, skeletal muscle, lungs, and surrounding or within blood vessels throughout the body. Many of the horses had dermal melanomas for years (range 1-6 years) before succumbing to metastatic disease. Histologic characteristic of dermal masses was not predictive of malignancy in the majority of cases. Treatment consisting of surgical debulking and administration of cimetidine, an autogenous vaccine, or both was attempted in 4 horses with no effect on outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12141308     DOI: 10.1892/0891-6640(2002)016<0452:mmih>2.3.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  15 in total

Review 1.  Salivary gland neoplasms in non-human primates: A case series and brief literature review.

Authors:  Emily Howard; Olga Gonzalez; Sanjeev Gumber; Daniel C Anderson; Shyamesh Kumar; Edward Dick
Journal:  J Med Primatol       Date:  2019-04-02       Impact factor: 0.667

Review 2.  Equine clinical genomics: A clinician's primer.

Authors:  M M Brosnahan; S A Brooks; D F Antczak
Journal:  Equine Vet J       Date:  2010-10       Impact factor: 2.888

3.  Isolation, establishment, and characterization of ex vivo equine melanoma cell cultures.

Authors:  Sarah W Kamau Chapman; Nadine Metzger; Paula Grest; Karsten Feige; Brigitte von Rechenberg; Jörg A Auer; Michael O Hottiger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-12-05       Impact factor: 2.416

4.  Establishment and characterization of a primary and a metastatic melanoma cell line from Grey horses.

Authors:  Monika H Seltenhammer; Elisabeth Sundström; Claudia Meisslitzer-Ruppitsch; Petra Cejka; Jedrzej Kosiuk; Josef Neumüller; Marlene Almeder; Otto Majdic; Peter Steinberger; Udo M Losert; Johannes Stöckl; Leif Andersson; Johann Sölkner; Monika Vetterlein; Anna Golovko
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-28       Impact factor: 2.416

Review 5.  Beyond tradition and convention: benefits of non-traditional model organisms in cancer research.

Authors:  Rebecca M Harman; Sanjna P Das; Arianna P Bartlett; Gat Rauner; Leanne R Donahue; Gerlinde R Van de Walle
Journal:  Cancer Metastasis Rev       Date:  2020-10-28       Impact factor: 9.264

Review 6.  "Animal-Type Melanoma/Pigmented Epithelioid Melanocytoma": History and Features of a Controversial Entity.

Authors:  Gerardo Cazzato; Francesca Arezzo; Anna Colagrande; Antonietta Cimmino; Teresa Lettini; Sara Sablone; Leonardo Resta; Giuseppe Ingravallo
Journal:  Dermatopathology (Basel)       Date:  2021-07-05

7.  Preliminary Study: Proteomic Profiling Uncovers Potential Proteins for Biomonitoring Equine Melanocytic Neoplasm.

Authors:  Parichart Tesena; Amornthep Kingkaw; Wanwipa Vongsangnak; Surakiet Pitikarn; Narumon Phaonakrop; Sittiruk Roytrakul; Attawit Kovitvadhi
Journal:  Animals (Basel)       Date:  2021-06-27       Impact factor: 2.752

Review 8.  IL-12 based gene therapy in veterinary medicine.

Authors:  Darja Pavlin; Maja Cemazar; Gregor Sersa; Natasa Tozon
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

9.  RACK1, a clue to the diagnosis of cutaneous melanomas in horses.

Authors:  Cécile Campagne; Sophia Julé; Florence Bernex; Mercedes Estrada; Geneviève Aubin-Houzelstein; Jean-Jacques Panthier; Giorgia Egidy
Journal:  BMC Vet Res       Date:  2012-06-29       Impact factor: 2.741

10.  Malignant melanoma in a grey horse: case presentation and review of equine melanoma treatment options.

Authors:  Lucy Va Metcalfe; Peter J O'Brien; Stratos Papakonstantinou; Stephen D Cahalan; Hester McAllister; Vivienne E Duggan
Journal:  Ir Vet J       Date:  2013-11-06       Impact factor: 2.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.